Photodynamic Therapy Overcoming the Hypoxia Microenvironment in Tumor Tissues-Juniper Publishers
Authored by Zheng Ruan
    
    
    
    
Abstract
Keywords: Photodynamic therapy; Bladder cancer; Boron-dipyrromethene
Abbreviations: PDT: Photodynamic Therapy; PS: Photo Sensitizers; ROS: Reactive Oxygen Species; ISC: Intersystem’s Crossing
Opinion
Photodynamic therapy (PDT) has been broadly exploited
 as an substitute therapeutic for cancer treatment since it was first 
allowed for the treatment of bladder cancer in 1993 [1]. It depends on 
the ability of photo sensitizers (PS) to transfer energy from light 
irradiation to tumor-dissolved oxygen (O2) to produce cytotoxic reactive oxygen species (ROS) for killing cells [2,3]. In the presence of molecular oxygen (O2), PS photo activation results in the creation of reactive oxygen species (ROS) like singlet oxygen (O2)
 and damage to tumor tissues. Compared with other traditional cancer 
therapies such as chemotherapy, PDT is invasive and negligibly toxic 
[4]. Since treatment occurs only where light is delivered, it avoids 
systematic treatment. Moreover, PDT can cause an inflammation immune 
response and enlargement of anti-tumor immune surveillance. These 
primary and secondary reaction mechanisms provide great inspiration for 
developing PDT for cancer treatment [5].
First of all, the high efficiency of the PDT agent 
itself should be emphasized. The photo sensitizer with higher singlet 
oxygen quantum yield could yield more ROS after the same irradiation 
condition. Many dyes obtained from natural or synthetic sources with 
high intersystem’s crossing (ISC) which have been used for singlet 
oxygen reactions. The heavy atom effect has been a valuable chemical 
approach to increase ISC in several molecules including BODIPY 
chromophores [6]. Regarding of that, we have designed and synthesized a 
kind of boron-dipyrromethene derivative with bromine substituted 
(BDP-Br) which has shown excellent ability of generating reactive oxygen
 species (ROS) upon irradiation for PDT. Then, a simply PE Gylated 
BDP-Br (PEG-BDP) as some kind of macro photo sensitizer was prepared 
which has shown superior cellular uptake ability and high efficiency of 
imaging and curing to PDT therapy in vitro and in vivo [7].
However, the direct therapeutic effect of PDT depend on ROS such as singlet oxygen (O2)
 which has been still depend on oxygen supply in tissues [8]. Thus, a 
major barrier in photodynamic therapy (PDT) for higher efficiency is 
hypoxia environment in tumor area and PDT-induced incessant consumption 
of oxygen. Owing to the abnormal new blood vessels and slack blood flow 
in tumor tissues, there comes inequity between oxygen supply and cancer 
cell oxygen consumption. Reported here to overcome this problem, we had 
designed and synthesized an oxygen self-sufficient nanoparticles by 
loading BODIPY into a water-dispersible fluorinated polypeptide drug 
delivery platform for high efficiency PDT [9]. Since the ability of 
higher oxygen capacity and O2 lifetime enhancement of 
perfluorocarbon, comparing with non-fluorinated polymeric platform, the 
whole PDT agent confirmed higher oxygen uptake and enhanced singlet 
oxygen production, showing the prospective to increase the PDT efficacy 
in hypoxic tumor environments after irradiation. Although the oxygen 
content in tumor area remains inadequate during PDT, enough O2
 can always be supplemented in the core of the nano carrier for 
photodynamic depletion by the BODIPY inside. Therefore, we can obtain 
enhanced PDT efficacy in vitro and in vivo  which can overcome the limitation of hypoxia microenvironment in tumor areas in the clinical use of PDT
For more details Academic Journal of Polymer Science please
click on: https://juniperpublishers.com/ajop/index.php
To know more about PeerReview Academic Journal of Polymer Science (AJOP)                    
Comments
Post a Comment